Aligos Therapeutics, Inc.(ALGS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALGS Aligos Therapeutics, Inc.

已收盘 11-22 16:00:00 EST

20.04

+0.25

+1.26%

盘后20.00

-0.04-0.20%

19:59 EST

最高20.44	最低18.75	成交量43.77万
今开20.01	昨收19.79	日振幅8.54%
总市值7,438万	流通市值2,938万	总股本371.16万
成交额864.24万	换手率29.86%	流通股本146.59万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALGS","market":"US","secType":"STK","nameCN":"Aligos Therapeutics, Inc.","latestPrice":20.04,"timestamp":1732309200000,"preClose":19.79,"halted":0,"volume":437712,"hourTrading":{"tag":"盘后","latestPrice":20,"preClose":20.04,"latestTime":"19:59 EST","volume":17045,"amount":344112.9638,"timestamp":1732323583313},"delay":0,"floatShares":1465900,"shares":3711585,"eps":-15.663465,"marketStatus":"已收盘","marketStatusCode":5,"change":0.25,"latestTime":"11-22 16:00:00 EST","open":20.01,"high":20.44,"low":18.7506,"amount":8642449.230624,"amplitude":0.085366,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.663465,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1602820800000,"adjPreClose":19.79,"preHourTrading":{"tag":"盘前","latestPrice":20.11,"preClose":19.79,"latestTime":"09:29 EST","volume":3632,"amount":73477.64816000001,"timestamp":1732285799999},"postHourTrading":{"tag":"盘后","latestPrice":20,"preClose":20.04,"latestTime":"19:59 EST","volume":17045,"amount":344112.9638,"timestamp":1732323583313},"volumeRatio":0.629876,"impliedVol":0.1576,"impliedVolPercentile":0.0054},"requestUrl":"/m/hq/s/ALGS/tweets","defaultTab":"tweets","newsList":[{"id":"2485296043","title":"Aligos Therapeutics, Inc.盘中异动 快速跳水5.25%报18.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485296043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485296043?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:05","pubTimestamp":1732295156,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时05分，Aligos Therapeutics, Inc.股票出现异动，股价大幅下挫5.25%。截至发稿，该股报18.75美元/股，成交量14.6539万股，换手率4.08%，振幅7.23%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Replimune Group, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1825.23%、145.16%、92.01%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Apollomics Inc C/Wts 01/04/2028 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为72.32%、63.64%、46.37%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301055698e44347&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301055698e44347&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","ALGS","BK4139"],"gpt_icon":0},{"id":"2485414129","title":"Aligos Therapeutics, Inc.盘中异动 临近午盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485414129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485414129?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:33","pubTimestamp":1732206791,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日00时33分，Aligos Therapeutics, Inc.股票出现异动，股价大幅下跌5.16%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Biodexa Pharmaceuticals Plc、Briacell Therapeutics Corp.、Tff Pharmaceuticals, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为849.87%、488.15%、130.41%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为162.20%、81.04%、76.33%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122003311abd51a9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122003311abd51a9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","ALGS"],"gpt_icon":0},{"id":"2484148969","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大涨5.03%报19.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484148969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484148969?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:45","pubTimestamp":1732113914,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时45分，Aligos Therapeutics, Inc.股票出现异动，股价快速拉升5.03%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Silexion Therapeutics Corp、Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为773.02%、293.86%、136.80%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp、Forte Biosciences, Inc.，振幅分别为113.86%、56.10%、44.03%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224515abd238d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224515abd238d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2484990926","title":"Aligos Therapeutics, Inc.盘中异动 股价大涨5.67%报21.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484990926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484990926?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:19","pubTimestamp":1732029599,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时19分，Aligos Therapeutics, Inc.股票出现波动，股价快速上涨5.67%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.20%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Exicure, Inc.、Tenaya Therapeutics, Inc.涨幅较大，Tff Pharmaceuticals, Inc.、Exicure, Inc.、Hcw Biologics Inc.较为活跃，换手率分别为699.35%、99.49%、98.58%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为81.67%、62.18%、52.14%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111923195998e4388f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111923195998e4388f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALGS","BK4505","LENZ"],"gpt_icon":0},{"id":"2484676328","title":"Aligos Therapeutics, Inc.盘中异动 早盘急速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676328?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:36","pubTimestamp":1731940562,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时36分，Aligos Therapeutics, Inc.股票出现波动，股价快速拉升5.08%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Hcw Biologics Inc.、冠科美博、Exicure, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为532.21%、244.40%、206.82%，振幅较大的相关个股有Hcw Biologics Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、冠科美博，振幅分别为67.89%、37.19%、34.31%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360295be48b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360295be48b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","ALGS","BK4139"],"gpt_icon":0},{"id":"2483802277","title":"Aligos Therapeutics, Inc.盘中异动 大幅跳水5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483802277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483802277?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:32","pubTimestamp":1731594732,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时32分，Aligos Therapeutics, Inc.股票出现异动，股价大幅下挫5.56%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Elevai Labs, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1472.07%、20.13%、11.37%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc.，振幅分别为36.36%、22.67%、15.53%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223212abc15a28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223212abc15a28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","ALGS"],"gpt_icon":0},{"id":"2483881638","title":"Aligos Therapeutics, Inc.盘中异动 早盘股价大涨6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483881638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483881638?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:32","pubTimestamp":1731508338,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时32分，Aligos Therapeutics, Inc.股票出现异动，股价大幅拉升6.16%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Mersana Therapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为329.62%、174.16%、84.72%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Mersana Therapeutics, Inc.、Lexeo Therapeutics, Inc.，振幅分别为14.89%、10.27%、9.75%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223218971a6475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223218971a6475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","BK4139","ALGS"],"gpt_icon":0},{"id":"2482757430","title":"Aeon Biopharma, Inc.盘中异动 急速上涨6.13%报0.796美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482757430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482757430?lang=zh_cn&edition=full","pubTime":"2024-11-12 03:42","pubTimestamp":1731354134,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日03时42分，Aeon Biopharma, Inc.股票出现异动，股价快速上涨6.13%。截至发稿，该股报0.796美元/股，成交量12.5942万股，换手率0.32%，振幅7.48%。Aeon Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.85%。Aeon Biopharma, Inc.公司简介：Priveterra Acquisition Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on November 17, 2020 and is headquartered in Fort Lauderdale, FL.（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112034214a22d6cbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112034214a22d6cbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","BK4505","BK4139","AEON"],"gpt_icon":0},{"id":"2482752289","title":"Os Therapies Incorporated盘中异动 下午盘股价大跌10.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482752289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482752289?lang=zh_cn&edition=full","pubTime":"2024-11-12 03:30","pubTimestamp":1731353438,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日03时30分，Os Therapies Incorporated股票出现波动，股价急速下跌10.53%。截至发稿，该股报2.55美元/股，成交量4966股，换手率0.02%，振幅3.75%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为0.82%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112033039971a5cb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112033039971a5cb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","ALGS","OSTX"],"gpt_icon":0},{"id":"2482751020","title":"Surrozen Inc C/Wts 01/08/2031 (To Pur Com)盘中异动 股价大涨7.00%报0.011美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482751020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482751020?lang=zh_cn&edition=full","pubTime":"2024-11-12 02:49","pubTimestamp":1731350941,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日02时49分，Surrozen Inc C/Wts 01/08/2031 股票出现异动，股价急速拉升7.00%。截至发稿，该股报0.011美元/股，成交量100股，换手率0.00%，振幅0.00%。Surrozen Inc C/Wts 01/08/2031 股票所在的生物技术行业中，整体跌幅为0.71%。Surrozen Inc C/Wts 01/08/2031 公司简介：Surrozen Inc 是一家临床阶段的生物技术公司，致力于发现和开发候选药物，以选择性地调节 Wnt 通路——一种多种器官和组织中组织修复的关键介质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111202490195be12b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111202490195be12b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","SRZNW","BK4505","BK4139"],"gpt_icon":0},{"id":"2482751057","title":"Kodiak Sciences Inc盘中异动 下午盘大幅拉升5.18%报5.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482751057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482751057?lang=zh_cn&edition=full","pubTime":"2024-11-12 02:46","pubTimestamp":1731350783,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日02时46分，Kodiak Sciences Inc股票出现波动，股价快速拉升5.18%。截至发稿，该股报5.18美元/股，成交量19.628万股，换手率0.37%，振幅6.00%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.71%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111202462498e41de2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111202462498e41de2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","ALGS","KOD"],"gpt_icon":0},{"id":"2482756771","title":"Purple Biotech Ltd盘中异动 急速下跌5.69%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482756771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482756771?lang=zh_cn&edition=full","pubTime":"2024-11-12 02:24","pubTimestamp":1731349489,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日02时24分，Purple Biotech Ltd股票出现异动，股价大幅下跌5.69%。截至发稿，该股报2.65美元/股，成交量2.1148万股，换手率1.35%，振幅7.83%。Purple Biotech Ltd股票所在的生物技术行业中，整体跌幅为0.68%。Purple Biotech Ltd公司简介：Purple Biotech Ltd 是一家临床阶段公司，专注于推进一流疗法以克服肿瘤免疫逃避和耐药性，并为癌症患者创造治疗方法。其肿瘤管线包括 NT219 和 CM24。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112022449a22d4fcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112022449a22d4fcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALGS","BK4505","BK4139","PPBT"],"gpt_icon":0},{"id":"2482756772","title":"Renovaro Inc.盘中异动 下午盘急速下挫5.13%报0.602美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482756772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482756772?lang=zh_cn&edition=full","pubTime":"2024-11-12 02:22","pubTimestamp":1731349335,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日02时22分，Renovaro Inc.股票出现波动，股价急速下挫5.13%。截至发稿，该股报0.602美元/股，成交量15.8586万股，换手率0.10%，振幅7.89%。Renovaro Inc.股票所在的生物技术行业中，整体跌幅为0.70%。其相关个股中，Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Lakeshore Biopharma Co., Ltd涨幅较大，Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为747.39%、501.89%、246.95%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Lakeshore Biopharma Co., Ltd，振幅分别为132.14%、72.42%、61.39%。Renovaro Inc.公司简介：Renovaro Inc是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112022215a22d4ef2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112022215a22d4ef2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALGS","RENB","BK4505","LBBB"],"gpt_icon":0},{"id":"2482737535","title":"Cormedix Inc.盘中异动 大幅拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482737535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482737535?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:42","pubTimestamp":1731343321,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时42分，Cormedix Inc.股票出现波动，股价大幅拉升5.09%。Cormedix Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为651.37%、483.81%、194.73%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Lakeshore Biopharma Co., Ltd，振幅分别为123.43%、72.42%、61.39%。Cormedix Inc.公司简介：Cormedix Inc 是一家生物制药公司，专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112004201971a5c45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112004201971a5c45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","ALGS","CRMD","BK4505"],"gpt_icon":0},{"id":"2482737938","title":"Xbiotech Inc.盘中异动 临近午盘快速下挫5.83%报7.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482737938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482737938?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:39","pubTimestamp":1731343145,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时39分，Xbiotech Inc.股票出现波动，股价快速下挫5.83%。截至发稿，该股报7.11美元/股，成交量1.2922万股，换手率0.04%，振幅6.22%。Xbiotech Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Xbiotech Inc.公司简介：XBiotech Inc 是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112003905971a5c41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112003905971a5c41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XBIT","BK4505","BK4139","LBBB","ALGS"],"gpt_icon":0},{"id":"2482738868","title":"Aligos Therapeutics, Inc.盘中异动 早盘大幅拉升10.21%报11.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738868?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:31","pubTimestamp":1731335495,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时31分，Aligos Therapeutics, Inc.股票出现波动，股价大幅上涨10.21%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为406.78%、125.83%、61.28%，振幅较大的相关个股有Proqr Therapeutics N.V.、Arcturus Therapeutics Holdings Inc.、Larimar Therapeutics, Inc.，振幅分别为103.25%、103.24%、103.20%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223135abb6612c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223135abb6612c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALGS","BK4505"],"gpt_icon":0},{"id":"2482148981","title":"Aligos Therapeutics, Inc.2024财年第三财季实现净利润-19.26百万美元，同比减少6.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482148981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482148981?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:00","pubTimestamp":1731081623,"startTime":"0","endTime":"0","summary":"11月9日，Aligos Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-19.26百万美元，同比减少6.76%；其中营业收入为1.27百万美元，同比减少60.80%，每股基本收益为-3.07美元。机构评级：截至2024年11月9日，当前有3家机构对Aligos Therapeutics, Inc.目标价做出预测，其中目标均价为103.33美元，其中最低目标价为60.00美元，最高目标价为175.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000055a224f574&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000055a224f574&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALGS"],"gpt_icon":0},{"id":"2481579938","title":"Aligos Therapeutics, Inc.盘中异动 临近午盘快速跳水5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481579938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481579938?lang=zh_cn&edition=full","pubTime":"2024-11-07 00:34","pubTimestamp":1730910849,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日00时34分，Aligos Therapeutics, Inc.股票出现波动，股价快速下跌5.39%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Sonnet Biotherapeutics Holdings, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为2766.39%、345.06%、117.61%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为73.16%、56.37%、51.52%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107003410a21d6ec2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107003410a21d6ec2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","ALGS","LENZ","BK4139"],"gpt_icon":0},{"id":"2481504985","title":"Aligos Therapeutics Inc    预计每股亏损 2.16 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481504985","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481504985?lang=zh_cn&edition=full","pubTime":"2024-11-05 05:37","pubTimestamp":1730756228,"startTime":"0","endTime":"0","summary":"   * Aligos Therapeutics Inc    将于11月6日公布截至2024年9月30日的财报，预计季度收入将出现下降。* 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司的营收预计将从去年同期的324万美元下降89.7%，至33.33万美元。* LSEG 的分析师平均预计 Aligos Therapeutics Inc 每股亏损 2.16 美元。* 华尔街对 Aligos Therapeutics Inc 的 12 个月目标价中位数为 75.00 美元，高于其上次收盘价 9.55 美元。11月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ALGS"],"gpt_icon":0},{"id":"2480833690","title":"Aligos Therapeutics, Inc.盘中异动 大幅拉升5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480833690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480833690?lang=zh_cn&edition=full","pubTime":"2024-11-01 23:15","pubTimestamp":1730474149,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日23时15分，Aligos Therapeutics, Inc.股票出现波动，股价急速上涨5.32%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Athira Pharma, Inc.、Theriva Biologics, Inc.涨幅较大，Theriva Biologics, Inc.、Gri Bio, Inc.、Ensysce Biosciences, Inc.较为活跃，换手率分别为3335.06%、813.18%、696.48%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Immatics N V C/Wts 01/07/2025 ，振幅分别为122.67%、96.49%、60.77%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101231549971a3e56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101231549971a3e56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","ALGS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aligos.com","stockEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":1.6962},{"period":"3month","weight":0.4309},{"period":"6month","weight":0.3648},{"period":"1year","weight":0.1641},{"period":"ytd","weight":0.1922}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aligos Therapeutics, Inc.于2018年2月5日在特拉华州注册成立。该公司是临床阶段的生物制药公司，目前专注于开发新颖的疗法，以解决病毒和肝脏疾病中尚未满足的医疗需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.09065},{"month":2,"riseRate":0.5,"avgChangeRate":-0.008446},{"month":3,"riseRate":0,"avgChangeRate":-0.182952},{"month":4,"riseRate":0.5,"avgChangeRate":-0.053068},{"month":5,"riseRate":0.5,"avgChangeRate":-0.019355},{"month":6,"riseRate":0,"avgChangeRate":-0.219584},{"month":7,"riseRate":0.5,"avgChangeRate":0.035457},{"month":8,"riseRate":0.5,"avgChangeRate":0.03027},{"month":9,"riseRate":0,"avgChangeRate":-0.16494},{"month":10,"riseRate":0.5,"avgChangeRate":-0.021458},{"month":11,"riseRate":0.6,"avgChangeRate":0.271323},{"month":12,"riseRate":0.25,"avgChangeRate":0.038523}],"exchange":"NASDAQ","name":"Aligos Therapeutics, Inc.","nameEN":"Aligos Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aligos Therapeutics, Inc.(ALGS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aligos Therapeutics, Inc.(ALGS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aligos Therapeutics, Inc.,ALGS,Aligos Therapeutics, Inc.股票,Aligos Therapeutics, Inc.股票老虎,Aligos Therapeutics, Inc.股票老虎国际,Aligos Therapeutics, Inc.行情,Aligos Therapeutics, Inc.股票行情,Aligos Therapeutics, Inc.股价,Aligos Therapeutics, Inc.股市,Aligos Therapeutics, Inc.股票价格,Aligos Therapeutics, Inc.股票交易,Aligos Therapeutics, Inc.股票购买,Aligos Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aligos Therapeutics, Inc.(ALGS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aligos Therapeutics, Inc.(ALGS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}